Latest news

PCI Biotech to present poster at 4th Immunotherapy of cancer conference

Posted on Mar 21, 2017

Oslo, Norway, March 21, 2017 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present a poster of the fimaVacc technology at the 4th Immunotherapy of cancer conference (IOTC4) – the leading international conference providing a global platform in Europe for translational research in the […]

Fourth quarter and preliminary 2016 report and presentation

Posted on Feb 28, 2017

Oslo, 28 February 2017 – Please find enclosed the financial report and presentation for fourth quarter and preliminary full year 2016. PCIB Q4 2016 Report PCIB Q4 2016 Presentation Highlights fimaCHEM Completed Phase I study in bile duct cancer, with early promising results confirmed at central expert review Oral presentation of the Phase I results […]

Invitation to fourth quarter 2016 presentation

Posted on Feb 20, 2017

Oslo, 20 February 2017 – PCI Biotech invites to a presentation of the company’s fourth quarter 2016 report on Tuesday 28 February 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday February 28, 11am – 12noon CET (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo. […]